![](/img/cover-not-exists.png)
Treatment outcomes with ixekizumab in patients with moderate-to-severe psoriasis who have or have not received prior biological therapies: an integrated analysis of 2 Phase III randomised studies
Gottlieb, A.B., Lacour, J.-P., Korman, N., Wilhelm, S., Dutronc, Y., Schacht, A., Erickson, J., Zhang, L., Mallbris, L., Gerdes, S.Language:
english
Journal:
Journal of the European Academy of Dermatology and Venereology
DOI:
10.1111/jdv.13990
Date:
October, 2016
File:
PDF, 662 KB
english, 2016